Ref ID: 18667
Author:
S. Blot, PhD – prof1, J. Rello, PhD – prof 2, G. Dimopoulos, PhD – prof 3, K. Vandewoude, PhD – prof 1, D. Vogelaers, PhD – prof 1, and the AspICU study investigators;
Author address:
1Ghent Univ, Gent, Belgium, 2Vall d’hebron Univ Hosp, Barcelona, Spain, 3Athens Attikon Univ. Hosp., Athens, Greece.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Invasive pulmonary aspergillosis (IPA) has a bad prognosis. We investigated outcome and risk factors for IPA in a cohort of ICU patients with IPA. Methods: We performed a multicentre (n=30) observational cohort study (11/2006-01/2011) including ICU patients with ≥ 1 Aspergillus-positive culture (n=563). We selected patients with a diagnosis of proven (1), probable (1), or putative (2) IPA (n=278). Diagnoses were based on revised EORTC/Mycoses Study Group criteria (1) and a recently validated clinical algorithm (2). Results: The cohort included 83 cases of proven, 32 of probable, and 163 of putative IPA. Median (interquartile range) age was 64y (54-73), 81% had a medical ICU admission, and the median APACHE II score was 24 (17-29). Only 5% had no underlying conditions. Classic host factors (1) were present in 72%. Predominant underlying conditions were COPD (34%), malignancy (23%), and solid organ transplant (16%). The cohort was characterized by a high rate of organ failure at time diagnosis: median SOFA score 10 (6-13), 91% ventilator support, 68% vasopressive/inotropic support, 36% of renal replacement therapy. 12-week mortality was 71%. Non-survivors were older (64 vs 56y), had higher APACHE II scores (25 vs 21), more frequent a medical ICU admission (84 vs 72%), more chronic heart failure (12 vs 4%), more chronic dialysis (5 vs 0%), and more prolonged use of corticosteroids (53 vs 38%) (all p<0.05). At time of diagnosis, non-survivors had more ventilation support (94 vs 82%), asopressive/inotropic support (76 vs 51%), renal replacement therapy (42 vs 22%), and higher SOFA scores (11 vs 7). Independent predictors of mortality as identified by Cox regression were: medical ICU admission (hazard ratio (HR) 1.73; 95% confidence interval (CI) 1.17-2.56), older age (HR 1.01; 95% CI 1.00-1.02), and higher SOFA scores (HR 1.05; 1.02-1.08). Antifungal therapy did not alter the prognosis. Conclusions: Mortality in ICU patients with IPA is high. Older age and multiorgan failure indicate a worse prognosis. References. (1) De Pauw B, et al. Clin Infect Dis 2008 (2) Blot S, et al. Am J Respir Crit Care Med 2012.
Abstract Number: K-951
Conference Poster: y
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a